{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:42:41Z","timestamp":1792212161659,"version":"4.4.0"},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.8145-26","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:09:29Z","timestamp":1792015769000},"source":"Crossref","is-referenced-by-count":0,"title":["Changes in Gait Speed During a 12-Month Multidisciplinary Obesity Management Program Including Semaglutide: A Real-World Observational Study in Japanese Adults With Musculoskeletal Disorders"],"prefix":"10.2169","author":[{"given":"Masuomi","family":"Tomita","sequence":"first","affiliation":[{"name":"Diabetes Center, Shimokitazawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiya","family":"Harashima","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Shimokitazawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Shimokitazawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Shimokitazawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Nagasaki","sequence":"additional","affiliation":[{"name":"Podiatry Center, Shimokitazawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyota","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Podiatry Center, Shimokitazawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Hisamichi","sequence":"additional","affiliation":[{"name":"Podiatry Center, Shimokitazawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 384: 989-1002, 2021.","DOI":"10.1056\/NEJMoa2032183"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bliddal H, et al. Once-weekly semaglutide in persons with obesity and knee osteoarthritis. N Engl J Med 391: 1573-1583, 2024.","DOI":"10.1056\/NEJMoa2403664"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Karakasis P, et al. Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis. Metabolism 164: 156113, 2025.","DOI":"10.1016\/j.metabol.2024.156113"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Studenski S, et al. Gait speed and survival in older adults. JAMA 305: 50-58, 2011.","DOI":"10.1001\/jama.2010.1923"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Satake S, Arai H. The revised Japanese version of the Cardiovascular Health Study criteria (revised J-CHS criteria). Geriatr Gerontol Int 20: 992-993, 2020.","DOI":"10.1111\/ggi.14005"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Montero-Odasso M, et al. Gait velocity as a single predictor of adverse events in healthy seniors aged 75 years and older. J Gerontol A Biol Sci Med Sci 60: 1304-1309, 2005.","DOI":"10.1093\/gerona\/60.10.1304"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kosiborod MN, et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med 389: 1069-1084, 2023.","DOI":"10.1056\/NEJMc2312296"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Felson DT. Osteoarthritis as a disease of mechanics. Osteoarthritis Cartilage 21: 10-15, 2013.","DOI":"10.1016\/j.joca.2012.09.012"},{"key":"9","unstructured":"9. Ministry of Health, L.a.W. Guidelines for Appropriate Use of Semaglutide for Obesity Management. 2023, Ministry of Health, Labour and Welfare, Tokyo."},{"key":"10","unstructured":"10. Japan Society for the Study of Obesity. Clinical Practice Guidelines for Obesity Disease 2022. 2022, Life Science Publishing, Tokyo."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Linge J, Birkenfeld AL, Neeland IJ. Muscle mass and glucagon-like peptide-1 receptor agonists: adaptive or maladaptive response to weight loss? Circulation 150: 1288-1298, 2024.","DOI":"10.1161\/CIRCULATIONAHA.124.067676"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fransen M, et al. Exercise for osteoarthritis of the knee: a Cochrane systematic review. Br J Sports Med 49: 1554-1557, 2015.","DOI":"10.1136\/bjsports-2015-095424"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_8145-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:16:19Z","timestamp":1792210579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_8145-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":12,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8145-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"8145-26"}}